This finding aligns with prior studies showing that early molecular markers, such as amyloid processing, tau phosphorylation, and neuroinflammation, emerge in young models but that clinical symptoms, including memory impairment, become pronounced with age as oxidative stress and chronic inflammation accumulate [37,38,39]. The gene discussed is MAPT; the disease is memory impairment.